Outcomes of Chemotherapy-Related Febrile Neutropenia Vary by Region
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Immune checkpoint inhibitor retreatment in advanced melanoma is used in clinical practice, but there is a lack of evidence to support it, a study suggests.
The incidence of esophageal cancer increased significantly from 2005 to 2019, but the mortality rate decreased.
NCCN classification is associated with long-term outcomes in patients with localized prostate cancer, a new study suggests.
Medical oncologists in the United States have been writing fewer prescriptions for opioids since 2017, a new study suggests.
Patients with cancer continued to experience COVID-19-related disruptions to their care in 2022, results of a survey suggest.